PA
ROIV icon

Profund Advisors’s Roivant Sciences ROIV Stock Holding History

Profund Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Sell
56,751
-19,696
-26% -$582K 0.06% 196
2026
Q1 		$2.12M Sell
76,447
-36,586
-32% -$940K 0.08% 186
2025
Q4 		$2.45M Buy
113,033
+6,394
+6% +$126K 0.07% 171
2025
Q3 		$1.61M Sell
106,639
-20,902
-16% -$259K 0.05% 233
2025
Q2 		$1.44M Buy
127,541
+19,123
+18% +$207K 0.05% 233
2025
Q1 		$1.09M Sell
108,418
-33,014
-23% -$357K 0.05% 277
2024
Q4 		$1.67M Buy
141,432
+5,271
+4% +$62.3K 0.06% 208
2024
Q3 		$1.57M Sell
136,161
-20,563
-13% -$234K 0.06% 237
2024
Q2 		$1.66M Buy
156,724
+14,377
+10% +$158K 0.06% 206
2024
Q1 		$1.5M Sell
142,347
-1,768
-1% -$19.1K 0.06% 228
2023
Q4 		$1.62M Buy
144,115
+28,106
+24% +$274K 0.07% 220
2023
Q3 		$1.35M Sell
116,009
-11,869
-9% -$134K 0.07% 217
2023
Q2 		$1.29M Sell
127,878
-7,703
-6% -$68.9K 0.07% 256
2023
Q1 		$1M Buy
+135,581
New +$1.12M 0.06% 299

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Profund Advisors's ROIV Position: Q2 2026 in Review

Profund Advisors reduced its Roivant Sciences (ROIV) stake by 26% in Q2 2026, selling an estimated $582K and leaving 56,751 shares worth $2.01M. The position accounts for 0.06% of the portfolio, ranked #196.

Profund Advisors first reported a position in ROIV in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.45M in Q4 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Profund Advisors held 56,751 shares of Roivant Sciences worth $2.01M as of Q2 2026.
  • Profund Advisors sold 19,696 Roivant Sciences shares in Q2 2026, an estimated $582K.
  • Roivant Sciences made up 0.06% of Profund Advisors's portfolio in Q2 2026, its #196 holding.
  • Profund Advisors first reported a position in Roivant Sciences in Q1 2023 and has held it in 14 quarters since.
  • Profund Advisors's Roivant Sciences position peaked at $2.45M in Q4 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.